Menu
Search
|

Menu

Close
X

Melinta Therapeutics Inc MLNT.OQ (NASDAQ Stock Exchange Global Select Market)

4.36 USD
-- (--)
As of Mar 20
chart
Previous Close 4.36
Open --
Volume --
3m Avg Volume 63,683
Today’s High --
Today’s Low --
52 Week High 52.50
52 Week Low 3.22
Shares Outstanding (mil) 11.23
Market Capitalization (mil) 48.96
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 6 analysts

KEY STATS

Revenue (mm, USD)
FY18
96
FY17
12
FY16
18
EPS (USD)
FY18
-18.098
FY17
-29.094
FY16
-58.556
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
58.80
Price to Sales (TTM)
vs sector
0.51
8.99
Price to Book (MRQ)
vs sector
0.26
4.66
Price to Cash Flow (TTM)
vs sector
--
40.60
Total Debt to Equity (MRQ)
vs sector
61.09
17.49
LT Debt to Equity (MRQ)
vs sector
58.13
13.83
Return on Investment (TTM)
vs sector
-72.02
12.11
Return on Equity (TTM)
vs sector
-119.81
13.22

EXECUTIVE LEADERSHIP

Kevin Ferro
Chairman of the Board, Since
Salary: --
Bonus: --
John Johnson
Chief Executive Officer, Director, Since 2019
Salary: --
Bonus: --
Peter Milligan
Chief Financial Officer, Since 2018
Salary: --
Bonus: --
Lisa DeFrancesco
Senior Vice President - Investor Relations, Since 2018
Salary: --
Bonus: --
Lyn Baranowski
Senior Vice President - Corporate Development and Strategy, Since
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

300 George St Ste 301
NEW HAVEN   CT   06511-6663

Phone: +1312.7670291
Site: melinta.com/

Melinta Therapeutics, Inc. develops and commercializes novel antibiotics designed to provide therapeutic solutions. The Company’s lead product is Baxdela, an antibiotic approved by the United States food and drug administration (FDA) for use in the treatment of acute bacterial skin and skin structure infections (ABSSSI). The Company also has an extensive pipeline of preclinical and clinical stage products This pipeline includes many important classes of antibiotics, each targeted at a different segment of the anti-infective market.

SPONSORED STORIES